You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.
An Insight into Clinical Outcomes in Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study
This presentation of data from the CHESS II study, examines clinical outcomes by disease severity (mild, moderate, and severe), in adult persons with hemophilia A without FVIII inhibitors
Request medical material
Would you like to receive this poster via email to view later?